VCAM1 and Miyoshi myopathy: In MM, the increased expression of VCAM1 and its receptor, VLA-4, correlates with disease progression, and increased levels of soluble VCAM1 (sVCAM1) in MM correlate with advanced disease and poor OS [50,51].